Novartis (VTX:NOVN) stock has shown strong performance over the past three years, outpacing its underlying earnings growth. Despite the company’s earnings growth not matching the stock’s performance, Novartis has continued to deliver solid results in the market. Investors have seen positive returns on their investment in Novartis stock, indicating confidence in the company’s future prospects. While the earnings growth may not have been as robust as the stock performance, Novartis remains a strong contender in the market.